Emmaus Life Sciences, Inc.
EMMA
$0.07
$0.019.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 140.15% | -70.94% | 6.02% | -82.91% | 51.29% |
| Total Depreciation and Amortization | -6.67% | 0.00% | 0.00% | 275.00% | -20.00% |
| Total Amortization of Deferred Charges | -30.49% | -14.14% | 34.51% | 10.94% | 29.29% |
| Total Other Non-Cash Items | 202.78% | -55.49% | -19.63% | 225.78% | -495.06% |
| Change in Net Operating Assets | -125.59% | -23.68% | 117.14% | 220.40% | -153.99% |
| Cash from Operations | 592.15% | -115.57% | 440.10% | 114.06% | -1,142.29% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Investing | -- | -- | -- | -100.00% | -- |
| Total Debt Issued | -100.00% | -66.77% | 152.72% | -34.84% | 68.49% |
| Total Debt Repaid | 15.38% | 51.08% | -59.42% | -33.07% | -12.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -118.66% | -93.92% | 63.87% | -452.82% | 182.32% |
| Foreign Exchange rate Adjustments | 100.00% | 30.77% | -1,400.00% | -80.00% | -50.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 264.55% | -157.52% | 409.80% | -32.14% | -700.00% |